The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yep with targeting 15million revenue 2 million profit and new product coming next year. Extremely cheap.
Happy to have added to entry position last week (last trade today); good business with good prospects, Harris selling provides an excellent opportunity (imv)
Think it's obvious that Harris shares are still getting sold through brokers. Once its finishes it will move nicely.
Something like a new product launch hitting 800 stores & DTC promotional platform of 400,000 potential users? I think patience is the main thing holding IDP back - Great RNS & investors think *ah what we have to wait another 2 months for another (most likely) great RNS*. We'll get there, eventually!
unkind and unloved..we need a bumper deal Rns with increased sales (unlikely) to get this back above my original loss making levels. Fear of the bends if we rise too fast. LiL
HC sold 4m shares last week, 27% of company. Not only will this have created an overhang that MMs will slowly work down but some blocks were sold at 47p so at 60p there is a quick 25% risk free profit for some.
This is massively undervalued IMHO but it might take a week or 2 before things calm down.
In last week we know that revenues are up 38% - so one track for a record £2m 2020 profit and new product will be stocked in all 800 Superdrug stores from next March. So Superdrug will do a bulk buy of between £250k to £400k to stock these stores. This revenue is not in 2020 numbers so clearly de-risks the 2020 profit even further.
DYOR etc
Not sure what's going on. It will turn soon enough.
17 trades SINCE 0800hrs for a total of £40 k shouldn't devalue the company by more than 6%. I wonder whats causing this drop?
I can't help wondering if some people bought in expecting a quick bounce ........ which hasn't happened. Now they want out?
I don't know. As someone else pointed out last week, there could still be some 'churning' going on for a while till the ex HC shares are in safer hands.
Looks like IDP just hit another 52 Week low. Time will tell if Joe Bayer is a competent and respected replacement Executive Chairman and this will go some way to helping the share price recover. I agree the board needs some extra ballast and hopefully this will be resolved shortly.
What the hello. Who keeps selling at the lows.
HC was on a little over £100k last year I think, year before as CEO he was on over £150k. None of the IDP Board are on silly money - quite well managed from that perspective.
HC will need to be replaced though as Board is now quite 'lite' and in last year he was focusing on Life Science division so somewhere else will need to pick that up
Added. Near all time low. Company in great shape. Profitable and organically growing year on year. Cash of 2mil and no debt.
What was HC's salary out of interest? Should be a nice cost saving there...
Not the start one would have hoped for! Still, Rome wasn't built in a day and some buying momentum is needed to get this share price moving upwards!
Wow this should get moving tomorrow and fast